MC
Ming capital
Venture CapitalQuietMing capital is a Shenzhen (China) originated global healthcare venture capital firm.
3
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Ming capital.
Investment Thesis & Strategy
Ming Capital invests in various stages of fintech and venture capital companies, with a focus on global healthcare ventures.
Investment Activity
Deals per year over the last 3 years
3
20172
20187
2019Portfolio Companies
Selected investments from their portfolio of 3 companies
T
TransThera Biosciences
Biotech · Series B, 2019
N
New Horizon Health
Healthcare · Series C+, 2019
A
Adlai Nortye
Biotech · Series B, 2019
V
Vcanbio
Biotech · Series B, 2019
G
Genecast
Biotech · Series B, 2019
E
EpimAb Biotherapeutics
Biotech · Series B, 2019
3
3D Medicines
Biotech · Series B, 2019
E
Elpiscience
Biotech · Series B, 2018
S
Singlera Genomics
Biotech · Series B, 2018
Z
Zhejiang Weiming Environment Protection
Cleantech · Growth, 2017
L
Lepu Medical
Healthcare · Growth, 2017
A
AccuraGen
Biotech · Series B, 2017
Frequently Asked Questions
Ming capital focuses on Series A, Series B, Series C+ stage investments.